Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 16

1166P - Social determinants of lung cancer in East London

Date

10 Sep 2022

Session

Poster session 16

Topics

Cancer Care Equity Principles and Health Economics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Catarina Alves Soares

Citation

Annals of Oncology (2022) 33 (suppl_7): S448-S554. 10.1016/annonc/annonc1064

Authors

C. Alves Soares, F. Chamberlain, U. Mukherjee, W. Ricketts, J. Conibear, J. Steele, P.W. Szlosarek, F.L. Lim, A. Januszewski

Author affiliations

  • Barts Thorax Centre, St. Bartholomew's Hospital - Barts Health NHS Trust, EC1A 7BE - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1166P

Background

In England more deprived groups are more likely to acquire lung cancer and have a higher associated mortality despite adjusting for disease stage at diagnosis and comorbidities [1]. More deprived populations are more frequently exposed to risk factors for disease development such as smoking and air pollution [2]. St Bartholomew’s Hospital serves a diverse population from East London. We aim to understand if there are associations between clinico-pathological features of lung cancer and levels of deprivation in our region.

Methods

Electronic patient records were reviewed for patients diagnosed with lung adenocarcinoma at our centre over 1 year between January and December 2021. Deprivation deciles were obtained via the English Indices for Deprivation 2019 [3].

Results

170 patients were identified, of which 75.3% (n=128) had an oncogenic driver mutation. Median age was 69 years with 45.3% females (n=77). The most frequently identified mutation was KRAS (n=62, 36%), followed by EGFR (n=18, 10.6%). 6.5% of patients (n=11) had 2 or more mutations. EGFR was associated with higher deprivation in the living environment subdomain (p=0.046), measuring exposure to poor quality air and housing, road traffic accidents and access to central heating. No other significant relationships between deprivation score and tumour mutational status were identified.

Conclusions

Lung cancer patients at our centre are distributed along a deprivation gradient, comparable to the local population makeup. Considering EGFR’s association with never-smoking populations, these findings are consistent with the hypothesis that these populations are also exposed to important oncogenic factors beyond smoking tobacco [2] and that a drive to reduce the burden of cancer must not be limited to smoking cessation alone. References [1] NCRAS, “Cancer by Deprivation in England 1996 - 2011,” 2014. [2] H. A. Powell, “Socioeconomic deprivation and inequalities in lung cancer: time to delve deeper?,” Thorax, vol. 74, no. 1. England, pp. 11–12, Jan-2019. [3] “National Statistics English Indices of Deprivation,” 2019. [Online]. Available: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019. [Accessed: 24-Mar-2022].

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.